---
category: news
title: "BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced promising top-line data from its Phase 2 trial of BXCL701,"
publishedDateTime: 2023-01-11T13:43:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-promising-top-line-results-from-/2023/01/11/9741357.htm"
webUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-announces-promising-top-line-results-from-/2023/01/11/9741357.htm"
type: article

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

secured: "cOiupMfJ454I5BI9uNgsdRcf9dVu8dSuJXVKbsHuFQqmV86vJknppN6e9207BthPV4LQz3I7FP+hvkXTCBAkxlPyWkZR3Hqeh709d4Afm4bN10Rzl/hOotG4TVoN2yRlv5mF+u+gaxN0zJirnRAT+1jY7LqM2CeP/ukPb8+wOkF4gXmwK1YLjKB1w4NxTieYDqfVve+dTNMVQO0gpUobyEp2NkpxDWQ+bfH/7zjLFL83/QRuVockQgBoQeXVj3ye9RuPDC+eeBFmjRY5KE6f3hj15z57KoFumA8WvOCuldPktTdPHM5PF6d1zsxRkUTXcD9mtZRLCfE3kPvK3RovWMZzMRU0oeQ0uZFKXU735vE=;gARDkHOSmLKzAK9zZLRkhA=="
---

